Selected article for: "CT scan and significant improvement"

Author: Kasgari, H. A.; Samaee, H.; Samakkhah, S. A.; Moradimajd, P.
Title: Treatment with tocilizumab in a patient with COVID-19. (Special issue 2 on COVID-19.)
  • Cord-id: q86iwn3r
  • Document date: 2020_1_1
  • ID: q86iwn3r
    Snippet: In late December 2019, a global outbreak (pandemic) of the coronavirus was reported, which WHO named 2019-nCoV. The virus is now spreading rapidly and has affected many countries, including Iran. There is no definitive and effective treatment for this virus yet. This report aimed to define the effect of Tocilizumab in patient with COVID-19. This case report is about a 52-year-old man with COVID-19 that has been treated with tocilizumab. The reported patient had an acceptable improvement in oxyge
    Document: In late December 2019, a global outbreak (pandemic) of the coronavirus was reported, which WHO named 2019-nCoV. The virus is now spreading rapidly and has affected many countries, including Iran. There is no definitive and effective treatment for this virus yet. This report aimed to define the effect of Tocilizumab in patient with COVID-19. This case report is about a 52-year-old man with COVID-19 that has been treated with tocilizumab. The reported patient had an acceptable improvement in oxygen saturation but no significant change in lung CT scan. After 3 days treatment patient with Tocilizumab, extensive bilateral lungs involvement still exist but SPO2 level iimprovement up to 90%. According to the results, this drug had a positive impact on oxygen saturation. However, we cannot be certain whether this drug positively affected the patient's coronavirus disease.

    Search related documents:
    Co phrase search for related documents
    • Try single phrases listed below for: 1
    Co phrase search for related documents, hyperlinks ordered by date